» Articles » PMID: 18021337

Influence of Pregnancy on Ceftriaxone, Cefazolin and Gentamicin Pharmacokinetics in Caesarean Vs. Non-pregnant Sectioned Women

Overview
Specialties Pharmacology
Pharmacy
Date 2007 Nov 21
PMID 18021337
Citations 10
Authors
Affiliations
Soon will be listed here.
Abstract

Objective: To study the effect of pregnancy on postoperative ceftriaxone, cefazolin and gentamicin elimination rate constant, half-life, volume of distribution and systemic clearance.

Methods: Fifty-four patients undergoing caesarean section and 12 undergoing gynaecological surgery were given intravenous dose of ceftriaxone, cefazolin or gentamicin immediately before the operation, for chemoprophylaxis. The levels of antibiotics were measured in blood plasma, amniotic fluid and umbilical cord blood plasma by HPLC for the cephalosporins and by fluorescence polarization immunoassay for gentamicin. Pharmacokinetic parameters were estimated using a one-compartment model.

Results: Pregnancy significantly influenced the pharmacokinetics of ceftriaxone and gentamicin, but not that of cefazolin. Ceftriaxone constant of elimination decreased statistically significantly in caesarean-sectioned women relative to the non-pregnant subjects. Gentamicin constant of elimination increased significantly in caesarean-sectioned women relative to the controls. The concentrations of antibiotics in umbilical cord blood were higher, whereas they were substantially lower in amniotic fluid than in maternal plasma. Six hours after antibiotic administration, only the cefazolin concentrations exceeded the MIC for sensitive bacteria both in pregnant and in non-pregnant patients.

Conclusion: Analysis of the pharmacokinetic data suggests that a single-dose of cefazolin may well be the optimal preoperative prophylactic treatment for obstetrical and gynaecological surgical procedures.

Citing Articles

Physiologic Changes During Pregnancy and Impact on Small-Molecule Drugs, Biologic (Monoclonal Antibody) Disposition, and Response.

Eke A, Gebreyohannes R, Fernandes M, Pillai V J Clin Pharmacol. 2023; 63 Suppl 1:S34-S50.

PMID: 37317492 PMC: 10365893. DOI: 10.1002/jcph.2227.


The Pharmacokinetics and Target Attainment of Antimicrobial Drugs Throughout Pregnancy: Part III Non-penicillin and Non-cephalosporin Drugs.

Groen F, Prins J, Lub-de Hooge M, Winter H, Kosterink J, Touw D Clin Pharmacokinet. 2023; 62(3):399-434.

PMID: 36940039 PMC: 10042773. DOI: 10.1007/s40262-023-01226-6.


Timing of Adjunctive Azithromycin for Unscheduled Cesarean Delivery and Postdelivery Infection.

Sanusi A, Ye Y, Boggess K, Saade G, Longo S, Clark E Obstet Gynecol. 2022; 139(6):1043-1049.

PMID: 35675601 PMC: 9199590. DOI: 10.1097/AOG.0000000000004788.


Bioanalytical development and validation of liquid chromatographic-tandem mass spectrometric methods for the quantification of total and free cefazolin in human plasma and cord blood.

Crutchfield C, Marzinke M Pract Lab Med. 2017; 1:12-21.

PMID: 28932794 PMC: 5597705. DOI: 10.1016/j.plabm.2015.03.003.


Effect of Maternal Obesity on Maternal-Fetal Transfer of Preoperative Cefazolin at Cesarean Section.

Groff S, Fallatah W, Yang S, Murphy J, Crutchfield C, Marzinke M J Pediatr Pharmacol Ther. 2017; 22(3):227-232.

PMID: 28638306 PMC: 5473397. DOI: 10.5863/1551-6776-22.3.227.